Zoetis Inc
ZTS153.500USD
+1.199+0.79%
收盘 04/25, 16:00（美东）报价延迟15分钟
68.84B总市值
27.69市盈率 TTM
关于 Zoetis Inc 公司
Zoetis Inc. 是一家全球性动物保健公司。该公司专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物保健的发现、开发、制造和商业化。该公司通过两个部门运营：美国和国际部门。在每个运营部门中，该公司为伴侣动物和牲畜客户提供多样化的产品组合，包括杀虫剂、疫苗、皮肤病学、抗感染药、止痛药和镇静剂、其他药物和动物健康诊断。该公司直接在北美、欧洲、非洲、亚洲、澳大利亚和南美洲的约 45 个国家/地区销售其产品。该公司致力于将产品商业化，涉及八个核心物种：狗、猫和马（统称为伴侣动物）以及牛、家禽、猪、鱼和羊（统称为牲畜）。
公司简介
公司代码ZTS
公司名称Zoetis Inc
上市日期Feb 01, 2013
成立日期2012
CEOMs. Kristin C. Peck
员工数量13800
证券类型Ordinary Share
年结日Feb 01
公司地址10 Sylvan Way
城市PARSIPPANY
上市交易所NYSE Consolidated
国家United States of America
邮编07054
电话19738227000
网址https://www.zoetis.com/
公司代码ZTS
上市日期Feb 01, 2013
成立日期2012
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
27.69K
+155.58%
Mr. Robert W. Scully
Mr. Robert W. Scully
Independent Director
Independent Director
22.13K
--
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Mr. Robert J. Polzer, Ph.D.
Mr. Robert J. Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
27.69K
+155.58%
Mr. Robert W. Scully
Mr. Robert W. Scully
Independent Director
Independent Director
22.13K
--
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
收入明细
单位: USD更新时间: 4月6日 周日
单位: USD更新时间: 4月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Parasiticides
2.15B
23.26%
Vaccines
1.83B
19.74%
Dermatology
1.66B
17.88%
Anti-infectives
1.10B
11.88%
Pain and sedation
851.00M
9.19%
Other
1.67B
18.04%
地区USD
名称
营收
占比
United States
5.07B
54.82%
Other emerging markets
865.00M
9.35%
Other Developed
564.00M
6.09%
Brazil
414.00M
4.47%
Australia
319.00M
3.45%
Other
2.02B
21.82%
业务
地区
业务USD
名称
营收
占比
Parasiticides
2.15B
23.26%
Vaccines
1.83B
19.74%
Dermatology
1.66B
17.88%
Anti-infectives
1.10B
11.88%
Pain and sedation
851.00M
9.19%
Other
1.67B
18.04%
股东统计
更新时间: 2月21日 周五
更新时间: 2月21日 周五
持股股东
股东类型
持股股东
股东统计
占比
The Vanguard Group, Inc.
9.23%
BlackRock Institutional Trust Company, N.A.
5.14%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.59%
AllianceBernstein L.P.
2.65%
Other
74.94%
持股股东
股东统计
占比
The Vanguard Group, Inc.
9.23%
BlackRock Institutional Trust Company, N.A.
5.14%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.59%
AllianceBernstein L.P.
2.65%
Other
74.94%
股东类型
股东统计
占比
Investment Advisor/Hedge Fund
41.24%
Investment Advisor
38.76%
Research Firm
4.78%
Insurance Company
3.73%
Pension Fund
2.53%
Bank and Trust
2.49%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.23%
Corporation
0.14%
Other
3.68%
机构持股
更新时间: 1月19日 周日
更新时间: 1月19日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q1
3159
431.17M
96.28%
-7.99M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
2023Q1
2913
436.42M
94.33%
-5.14M
2022Q4
2889
436.14M
93.57%
-8.47M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
41.17M
9.19%
+127.66K
+0.31%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
22.94M
5.12%
-145.06K
-0.63%
Dec 31, 2024
State Street Global Advisors (US)
19.84M
4.43%
+63.50K
+0.32%
Dec 31, 2024
State Farm Insurance Companies
16.01M
3.58%
-26.09K
-0.16%
Dec 31, 2024
AllianceBernstein L.P.
11.81M
2.64%
-3.58M
-23.26%
Dec 31, 2024
Geode Capital Management, L.L.C.
10.62M
2.37%
+190.14K
+1.82%
Dec 31, 2024
Polen Capital Management, LLC
7.48M
1.67%
+1.12M
+17.54%
Dec 31, 2024
Managed Account Advisors LLC
7.02M
1.57%
-2.23M
-24.12%
Dec 31, 2024
Wellington Management Company, LLP
6.96M
1.55%
+3.06M
+78.46%
Dec 31, 2024
Capital World Investors
6.56M
1.47%
-121.21K
-1.81%
Dec 31, 2024
查看更多
持股ETF
更新时间: 4月6日 周日
更新时间: 4月6日 周日
机构名称
占比
ProShares Pet Care ETF
9.92%
VanEck Agribusiness ETF
7.64%
VanEck Pharmaceutical ETF
4.8%
Natixis Vaughan Nelson Select ETF
4.5%
iShares U.S. Pharmaceuticals ETF
4.38%
First Trust NASDAQ Pharmaceuticals ETF
3.85%
Honeytree US Equity ETF
3.83%
SPDR S&P Pharmaceuticals ETF
3.64%
Jensen Quality Growth ETF
3.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.55%
查看更多
ProShares Pet Care ETF
占比9.92%
VanEck Agribusiness ETF
占比7.64%
VanEck Pharmaceutical ETF
占比4.8%
Natixis Vaughan Nelson Select ETF
占比4.5%
iShares U.S. Pharmaceuticals ETF
占比4.38%
First Trust NASDAQ Pharmaceuticals ETF
占比3.85%
Honeytree US Equity ETF
占比3.83%
SPDR S&P Pharmaceuticals ETF
占比3.64%
Jensen Quality Growth ETF
占比3.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.55%
分红派息
近5年累计派现
2.94B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据